Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients with Multiple System Atrophy

14909TEVA-TV56286-NDG-20039OpenMulti-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients with Multiple System AtrophyTV56286-NDG-20039NCT06568237IndustrialAdultTreatmentOtherPagan, FernandoGeorgetown University Medical Center : Luke Lovelace; Lombardi Comprehensive Cancer Center : Luke LovelaceGUMC Neurology; GUMC PFS10704Luke LovelaceLuke Lovelacell928@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>